Phosphoinositide-dependent kinase-1 and protein kinase Cδ contribute to endothelin-1 constriction and elevated blood pressure in intermittent hypoxia

Journal of Pharmacology and Experimental Therapeutics

Volumn 344, Issue 1, 2013, Pages 68-76

  Webster, Bradley R ^a   Osmond, Jessica M ^a   Paredes, Daniel A ^a   DeLeon, Xavier A ^a   Jackson Weaver, Olan ^a   Walker, Benjimen R ^a   Kanagy, Nancy L ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO N [4 [5 (2 PHENANTHRENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]PHENYL]ACETAMIDE; ENDOTHELIN 1; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE C DELTA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HYPERTENSION; INTERMITTENT HYPOXIA; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; SLEEP DISORDERED BREATHING; WESTERN BLOTTING;

ANIMALS; ANOXIA; BLOOD PRESSURE; ENDOTHELIN-1; ENZYME INHIBITORS; IMMUNOPRECIPITATION; MALE; MESENTERIC ARTERIES; PHOSPHORYLATION; PROTEIN KINASE C-DELTA; PROTEIN-SERINE-THREONINE KINASES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SLEEP APNEA SYNDROMES; SULFONAMIDES; VASOCONSTRICTION;

EID: 84871675082     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.195412     Document Type: Article

References (27)

1. Allahdadi KJ, Cherng TW, Pai H, Silva AQ, Walker BR, Nelin LD, and Kanagy NL (2008a) Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia. Am J Physiol Heart Circ Physiol 295: H434-H440.
2. Allahdadi KJ, Duling LC, Walker BR, and Kanagy NL (2008b) Eucapnic intermittent hypoxia augments endothelin-1 vasoconstriction in rats: role of PKCdelta. Am J Physiol Heart Circ Physiol 294:H920-H927. (Pubitemid 351253304)
3. Allahdadi KJ, Walker BR, and Kanagy NL (2005) Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 45:705-709. (Pubitemid 40418369)
4. Bayascas JR, Wullschleger S, Sakamoto K, García-Martínez JM, Clacher C, Komander D, van Aalten DM, Boini KM, Lang F, and Lipina C, et al. (2008) Mutation of the PDK1 PH domain inhibits protein kinase B/Akt, leading to small size and insulin resistance. Mol Cell Biol 28:3258-3272.
5. Block K, Eid A, Griendling KK, Lee DY, Wittrant Y, and Gorin Y (2008) Nox4 NAD(P) H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression. J Biol Chem 283:24061-24076.
6. Bradley TD and Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373:82-93.
7. Dematteis M, Julien C, Guillermet C, Sturm N, Lantuejoul S, Mallaret M, Lévy P, and Gozal E (2008) Intermittent hypoxia induces early functional cardiovascular remodeling in mice. Am J Respir Crit Care Med 177:227-235.
8. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, and Zeiher AM (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601-605.
9. Gao M, Yeh PY, Lu YS, Hsu CH, Chen KF, Lee WC, Feng WC, Chen CS, Kuo ML, and Cheng AL (2008) OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma. Cancer Res 68:9348-9357.
10. Gao T, Toker A, and Newton AC (2001) The carboxyl terminus of protein kinase c provides a switch to regulate its interaction with the phosphoinositide-dependent kinase, PDK-1. J Biol Chem 276:19588-19596.
11. Gschwendt M, Dieterich S, Rennecke J, Kittstein W, Mueller HJ, and Johannes FJ (1996) Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett 392:77-80. (Pubitemid 26276722)
12. GschwendtM,Müller HJ, Kielbassa K, Zang R, KittsteinW, Rincke G, and Marks F (1994) Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199:93-98. (Pubitemid 24179919)
13. Kanagy NL, Walker BR, and Nelin LD (2001) Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 37:511-515. (Pubitemid 32199020)
14. Kikkawa U, Matsuzaki H, and Yamamoto T (2002) Protein kinase C delta (PKC delta): activation mechanisms and functions. J Biochem 132:831-839. (Pubitemid 36090647)
15. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, and Parker PJ (1998) Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281:2042-2045. (Pubitemid 28475494)
16. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marmé D, and Schächtele C (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem 268:9194-9197. (Pubitemid 23145960)
17. Newton AC (2009) Lipid activation of protein kinases. J Lipid Res 50 (Suppl): S266-S271.
18. Prasad N, Topping RS, Zhou D, and Decker SJ (2000) Oxidative stress and vanadate induce tyrosine phosphorylation of phosphoinositide-dependent kinase 1 (PDK1). Biochemistry 39:6929-6935. (Pubitemid 30390386)
19. Rybin VO, Guo J, Gertsberg Z, Elouardighi H, and Steinberg SF (2007) Protein kinase Cepsilon (PKCepsilon) and Src control PKCdelta activation loop phosphorylation in cardiomyocytes. J Biol Chem 282:23631-23638. (Pubitemid 47311967)
20. Snow JB, Kitzis V, Norton CE, Torres SN, Johnson KD, Kanagy NL, Walker BR, and Resta TC (2008) Differential effects of chronic hypoxia and intermittent hypocapnic and eucapnic hypoxia on pulmonary vasoreactivity. J Appl Physiol 104:110-118.
21. Soltoff SP (2007) Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta. Trends Pharmacol Sci 28:453-458.
22. Sonnenburg ED, Gao T, and Newton AC (2001) The phosphoinositide-dependent kinase, PDK-1, phosphorylates conventional protein kinase C isozymes by a mechanism that is independent of phosphoinositide 3-kinase. J Biol Chem 276:45289-45297.
23. Troncoso Brindeiro CM, da Silva AQ, Allahdadi KJ, Youngblood V, and Kanagy NL (2007) Reactive oxygen species contribute to sleep apnea-induced hypertension in rats. Am J Physiol Heart Circ Physiol 293:H2971-H2976. (Pubitemid 350106521)
24. Xiao-Yun X, Zhuo-Xiong C, Min-Xiang L, Xingxuan H, Schuchman EH, Feng L, Han- Song X, and An-Hua L (2009) Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells. Med Sci Monit 15:BR254-BR261.
25. Zeng G, Nystrom FH, Ravichandran LV, Cong LN, Kirby M, Mostowski H, and Quon MJ (2000) Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101:1539-1545. (Pubitemid 30180890)
26. Zhu J, Huang JW, Tseng PH, Yang YT, Fowble J, Shiau CW, Shaw YJ, Kulp SK, and Chen CS (2004) From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors. Cancer Res 64:4309-4318. (Pubitemid 38802438)
27. Zou MH, Hou XY, Shi CM, Kirkpatick S, Liu F, Goldman MH, and Cohen RA (2003) Activation of 59-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite. J Biol Chem 278:34003-34010. (Pubitemid 37553236)